BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/30/2024 10:05:38 AM | Browse: 43 | Download: 206
 |
Received |
|
2024-04-27 17:02 |
|
Peer-Review Started |
|
2024-04-27 17:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-25 09:17 |
|
Revised |
|
2024-09-03 11:37 |
|
Second Decision |
|
2024-09-23 02:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-09-23 09:43 |
|
Articles in Press |
|
2024-09-23 09:43 |
|
Publication Fee Transferred |
|
2024-09-26 08:17 |
|
Edit the Manuscript by Language Editor |
|
2024-10-10 14:24 |
|
Typeset the Manuscript |
|
2024-10-29 02:39 |
|
Publish the Manuscript Online |
|
2024-10-30 10:05 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Extramedullary plasmacytoma with the uvula as the first manifestation: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing Yang, Hui Peng, Sheng-Ke Tu, Min Li and Kui Song |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Innovation Platform and Talent Program of Hunan Province |
2021SK4050 |
|
| Corresponding Author |
Kui Song, MD, Chief Doctor, Department of Hematology, The First Affiliated Hospital of Jishou University, Intersection of Shiji Avenue and Jianxin Road, Jishou 416000, Hunan Province, China. js_hematology@163.com |
| Key Words |
Extramedullary plasmacytoma; Plasmacytoma; Uvula; Multiple myeloma; Case report |
| Core Tip |
The high-risk characteristics of extramedullary plasmacytoma in clinical manifestations stem from its pathogenesis and the high-risk trait of cytogenetics. There are limited recommendations and guidelines for this type of tumor owing to the rarity of extramedullary plasmacytoma (EMP) of the uvula. Radiotherapy is the preferred treatment after diagnosis. Chemotherapy is ideal for cases with multiple recurrence, extensive local invasion, and poor histological differentiation. The current chemotherapy regimen can refer to the chemotherapy regimen of multiple myeloma. We reported a rare case of EMP with the uvula as the first manifestation; therefore, relevant literature is reviewed to enhance clinicians' awareness of such rare comorbidities. |
| Publish Date |
2024-10-30 10:05 |
| Citation |
<p>Yang J, Peng H, Tu SK, Li M, Song K. Extramedullary plasmacytoma with the uvula as the first manifestation: A case report. <i>World J Clin Oncol</i> 2025; 16(1): 96131</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i1/96131.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i1.96131 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
